Jumpcode Genomics
Takara Bio, Jumpcode Genomics Cross-License CRISPR-Based RNA Depletion Tech
The partnership settles a patent dispute between the firms in Europe and enables both firms access to a worldwide IP portfolio.
In Brief This Week: BC Platforms, Thermo Fisher Scientific, Jumpcode Genomics, More
News items for the week of Nov. 28, 2022.
Element Biosciences Inks Two More Partnerships to Plug Sequencer Into Existing NGS Workflows
The deals will bring Dovetail Genomics' proximity ligation-based NGS library prep products and Jumpcode Genomics' CRISPRclean technology to users of the Aviti sequencer.
Jumpcode Genomics, TGen Partner to Test Metagenomic Approaches for COVID Detection
The company and institute are collaborating on the development of a diagnostic assay that uses Jumpcode's CRISPR-based reagents and TGen's NGS technology.
As diagnostics firms develop a new wave of COVID-19 tests using next-gen sequencing, TGen researchers are also adding CRISPR-based sample prep to their kit.